From Design to Delivery: A Translational Framework for Non-Viral Gene Editing
The rapid expansion of genomic medicine has intensified the need for scalable, regulatory-aligned and high-fidelity gene editing workflows that can efficiently transition from discovery to clinical evaluation. Aldevron and Integrated DNA Technologies (IDT) are at the forefront of a non-viral gene editing framework designed to support programs across in vivo and ex vivo therapeutic modalities. Emphasis is placed on editing specificity, off-target assessment and manufacturability to support IND-enabling studies.
In this webinar, you will be able to:
- Map a non-viral CRISPR-mediated gene editing workflow to support in vivo and ex vivo genomic medicine applications.
- Understand manufacturability and quality constraints needed to ensure consistency, traceability and IND readiness for complex editing components.
- Integrate off target safety profiling, analytical services and regulatory expectations into an evidence package that supports non viral gene editing IND filings.
Speakers
Ashley Jacobi, Director, Applications & Market Development, Integrated DNA Technologies (IDT)
Ashley received her Molecular Genetics & Biochemistry degree from Cornell College in 2006 and has spent the last 20 years in several roles within the Research & Product Development teams at IDT. She has conducted research in RNAi and antisense oligo technologies, and more recently focused on studying CRISPR gene editing. Ashley is also a certified practitioner in Customer Insight and leads external scientific collaborations at IDT.
Max Sellman, Senior Product Manager, Aldevron
Max Sellman is Senior Product Manager, Gene Editing, at Aldevron focusing on gene editing protein products and custom services since 2017. He partners closely with research and translational-phase clients to ensure they have the right tools and insights to drive successful therapeutic development. Max holds a bachelor’s degree from the University of Wisconsin in Genetics and Life Sciences Communication.
gatedform
gatedform
546005641
non-viral-gene-editing-wbn
add
Other
promotion
https://lifesciences.danaher.com/
https://help.salesforce.com/s/articleView?id=sf.mc_es_demanager.htm